Agilent Technologies Emphasizes LC/MS Life Science Workflows with new Proteomics Web Site
News Apr 17, 2008
Providing a useful new resource for proteomics researchers, Agilent Technologies Inc. has announced the launch of www.proteomics-lab.com that provides the latest instrument, software and workflow-related information.
The site provides overviews of common proteomics challenges including biomarker discovery, protein identification, quantitative proteomics, glycan and glycoprotein analysis, phosphoprotein analysis, and intact protein analysis. It also provides access to recent posters, applications technical notes, videos, events, promotions and information about innovative Agilent products designed to optimize sample preparation and analysis.
“Customers have made it clear that they’d like us to go beyond traditional instrument support to address complete proteomics workflows,” said Ken Miller, Agilent marketing director, LC/MS Division. “This is one of many resources we’re providing to maintain the strong momentum Agilent has achieved in many parts of the biodiscovery research spectrum, including genomics and metabolomics as well as proteomics.”
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE